Skip to Late-Breaking Abstracts »

All accepted abstracts are available in the Journal for ImmunoTherapy of Cancer (JITC).

Abstract Titles

Poster Presentation Dates

All odd numbered posters will be presented on Wednesday, Nov. 11, from 5:15-5:45 p.m. EST and Friday, Nov. 13, from 4:40-5:10 p.m. EST. Even numbered posters will be presented on Thursday, Nov. 12, from 4:50-5:20 p.m. EST and Saturday, Nov. 14, from 1-1:30 p.m. EST.

Posters will be on display from 8 a.m. on Monday, Nov. 9, until the virtual poster hall closes on December 31, 2020.

Search word or phrase:

# Type Title Authors Category Keywords
661 Poster Presentation Five immunotypic signatures identified in human glioblastoma correlate with tumor contact with the lateral ventricle, immune suppression, and patient outcome. Todd Bartkowiak, MS, PhD; Sierra M. Barone, BS; Madeline J. Hayes, BS; Allison R. Greenplate, Ph.D; Justine Sinnaeve, Ph.D.; Nalin Leelatian, M.D., Ph.D.; Akshitkumar M. Mistry, M.D.; Caroline E. Roe, MLS; Bret C. Mobley, M.D.; Lola B. Chambless, MD; Reid C. Thompson, M.D.; Kyle D. Weaver, M.D.; Rebecca A. Ihrie, Ph.D.; Jonathan M. Irish, Ph.D.; Todd Bartkowiak, MS, PhD; Machine Learning, Artificial Intelligence, and Computational Modeling Bioinformatics; Coinhibition; Cytokine; Immune contexture; Immune suppression; Myeloid cells; Solid tumors; Systems biology; Tumor infiltrating lymphocytes (TILs); Tumor microenvironment